SB Nation | Mark Coddington

List

December 23rd, 2011

Buy Tramadol No Prescription

[This review was originally posted at the Nieman Journalism Lab Buy Tramadol No Prescription, on Nov. 4, 2011.]

Should we rethink online paywalls?: It may not be grabbing as many headlines as it was a year ago, but the paid-content train keeps rollin' along, with two more newspapers jumping on board this week: Britain's The Independent is launching a metered paywall for readers outside the U.K. (powered by the Press+ system formerly of Journalism Online), and the Minneapolis Star Tribune is launching a metered model similar to that of the New York Times — 20 free page views a month, Cheap Tramadol no rx, after which the paywall kicks in. Print subscribers will have unlimited access, and the Strib estimates that it'll eventually get $3 million to $4 million in annual revenue from the plan.

On another paywall front, the Lab's Justin Ellis reported that Google, which has been working with publishers on paid content online for a while, has been quietly experimenting with a survey-as-paywall, in which visitors are asked to answer a survey question in order to gain access to the site, japan, craiglist, ebay, overseas, paypal.

This week's quarterly circulation numbers included some positive news about the New York Times' paywall, as Ken Doctor noted at the Lab last week: The New York Times' Sunday circulation actually went up, for the first time in five years, Buy Tramadol No Prescription. Poynter's Rick Edmonds pointed out that this quarter's numbers are the result of a formula in flux, but the good signs have people like NPR's David Folkenflik rethinking the value of online news paywalls.

Not everyone's high on paywalls, of course: After initially being surprised by the high numbers of subscribers to Newsday's online edition, Forbes' Jeff Bercovici found that the number paying for it on its own is still under 1,000. Is Tramadol safe, And GigaOM's Mathew Ingram said that despite its initial success, the Times' paywall is still a stopgap strategy — "an attempt to create the kind of artificial information scarcity that newspapers used to enjoy. And if that is all that newspapers are trying to do, the future looks pretty bleak indeed."

—

Yahoo's new personalized news app: Yahoo jumped into the tablet world this week, announcing the launch of several products for the iPad, including the social TV app IntoNow and Livestand, a "personalized living magazine" (yup, another one), discount Tramadol. Buy Tramadol No Prescription, The obvious point of comparison is Flipboard, and opinions were varied as to how well Livestand compares to Flipboard. Mashable's Ben Parr was pretty impressed, though he noted that Livestand and Flipboard are gathering their content in different ways — Flipboard through your social feeds, and Livestand through its content partners.

Others weren't quite so wowed. Kara Swisher of All Things Digital said Livestand shouldn't be anything new for Flipboard users, and Wired's Tim Carmody saw the difference between Flipboard and Livestand that Parr mentioned as a fundamental error by Yahoo. Tramadol overnight, Flipboard is built for readers, to allow them to distill the good stuff from their social and RSS feeds, he said. But "Yahoo’s Livestand only solves problems for publishers and advertisers: how to display content and advertising to readers without having to have everyone write their own code from scratch." The Lab's Ken Doctor gave several useful areas in which to evaluate Livestand and the coming tablet aggregator wars, Buy Tramadol No Prescription.

Advertising is a big part of what's new with Livestand: With it, they also unveiled Living Ads, which is the latest attempt to create a magazine-like ad on the tablet, using HTML5. As Adweek noted, generic Tramadol, the ads take up a third of the screen and are interactive, with animation and video available. These ads are pretty expensive, but Yahoo's Blake Irving told Business Insider they get advertisers away from the CPM model, which he believes hasn't served advertisers well.

—

Is Assange a step closer to the U.S.?: A week after WikiLeaks announced that it would temporarily shut down to raise money, Tramadol from canada, the whistleblowing website got some more bad news when a British high court ruled that WikiLeaks' founder, Julian Assange, can be extradited to Sweden on charges of sexual assault, rejecting an appeal of a ruling made earlier this year. Buy Tramadol No Prescription, Assange can still appeal to Britain's Supreme Court, but it's headed to Sweden to face trial.

Assange has opposed the extradition to Sweden because he contends that the rulers of that country are aligned against him, but the specter of another extradition is also looming: As Paul Sawers of The Next Web noted, Assange and his supporters are concerned that a move to Sweden would make it much easier for him to be sent to the United States, where the Obama administration and members of Congress have discussed prosecuting him for releasing sensitive information through WikiLeaks, where can i order Tramadol without prescription. Forbes' Andy Greenberg argued, however, that Assange would be more likely to be sent to the U.S. from Britain than from Sweden.

The Associated Press looked at whether WikiLeaks could survive Assange's extradition — its answer: probably not — and Swedish columnist Karin Olsson wrote in the Guardian that Assange has lost all of his intriguing man-of-mystery status in her country. But Australian journalist Matt da Silva urged people not to let up in their support of Assange, praising him as a crusader against government's efforts to manage and control the media, Buy Tramadol No Prescription.

—

Reconciling journalism and political views: What started a couple of weeks ago as yet another public radio conundrum regarding its employees and political opinions morphed into an interesting discussion about journalism and transparency. My Tramadol experience, Two public radio employees, Lisa Simeone of Soundprint and Caitlin Curran of WYNC's The Takeaway, were fired after taking part in Occupy Wall Street protests. Curran told her story at Gawker, and Brooke Gladstone, host of the NPR show On the Media, discussed NPR's policy in a live chat.

The Atlantic's Conor Friedersdorf argued that WNYC was wrong to fire Curran, buy Tramadol without prescription, pointing out that several NPR reporters have made essentially the same point she did in her protest sign, and have been praised for it. He and the Guardian's Dan Gillmor also made the case Buy Tramadol No Prescription, for doing away with the philosophy of viewlessness in the American press. As Gillmor put it, telling journalists they can't even hint at what they believe "puts a barrier between them and their audiences – a serious problem given that news and journalism are evolving from a lecture into a conversation." Though he wasn't discussing the public radio firings, Gawker's Hamilton Nolan did provide a counterargument, defending journalistic facelessness and an institutional writing style. Tramadol trusted pharmacy reviews, And as if on cue, former New York Sun editor Ira Stoll launched News Transparency, a site that lets people know about journalists' backgrounds as a kind of imposed transparency from the outside, as Poynter's Jeff Sonderman put it.

—

The Verge takes off: A new tech blog to watch: The sports blog network SB Nation launched a tech blog called The Verge this week, under the leadership of several former Engadget staffers. As part of the launch, SB Nation and The Verge will both fall under a new parent media called Vox Media, where can i buy cheapest Tramadol online. The site got some initial rave reviews over its updating story streams, something that SB Nation has been using for a while, Buy Tramadol No Prescription.

Business Insider has an interview with the folks behind the site, and the Lab's Justin Ellis talked about where SB Nation/Vox will go from here. The Lab's Joshua Benton also pulled three lessons for news orgs out of the site's development, emphasizing bold, tablet-style design, structured data, Tramadol class, and community.

—

Reading roundup: Tons of stuff going on this week. Here's the TL;DR version of the rest:

— Google began giving journalists photos next to their stories in Google News — but only if they have a Google+ account. Alexander Howard was OK with it Buy Tramadol No Prescription, , but Columbia's Emily Bell wasn't, calling it coercion and saying it only helped Google, not journalism.

— The St. Petersburg Times, a newspaper owned by the nonprofit Poynter Institute, announced it will change its name to the Tampa Bay Times on Jan. 1, order Tramadol online c.o.d, broadening its geographic focus. Poynter rounded up some of the reaction on social media and compared the decision to other recent newspaper name changes.

— Your weekly News Corp, Buy Tramadol No Prescription. phone hacking update: New documents released by a committee of Britain's Parliament revealed that a company attorney warned of a culture of hacking back in 2008. Here's the summary from News Corp.'s own Wall Street Journal and a blow-by-blow from the Guardian.

— As GigaOM's Colleen Taylor reported, Twitter has quietly unveiled new Top News and Top People search functions. Tramadol photos, Poynter's Jeff Sonderman looked at the effect it will have on publishers.

— Media analyst Frederic Filloux examined the sad state of web news design, and Amy Gahran of the Knight Digital Media Center said all the ugliness could help push users to the mobile web.

— The Guardian launched n0tice, their open community news platform. The Lab's Megan Garber took a look at the new site, and The Next Web's Martin Bryant examined it as a possible replacement for local newspapers.

— Finally, here's hoping this inspiring Lab post by Jacob Harris will forever put an end to the insipid question, "Will X save journalism?".

May 5th, 2011

Lipitor Price

[This review was originally posted at the Nieman Journalism Lab Lipitor Price, on April 8, 2011.]

Arianna's AOL thins its ranks: Some weeks are just like this: The three biggest stories were the Huffington Post, the New York Times, and the Huffington Post vs. the New York Times. I'll try to tackle them one at a time, starting with HuffPo (and AOL), then covering its battle with the Times, then going to the Times' paywall. Clear as mud, Lipitor gel, ointment, cream, pill, spray, continuous-release, extended-release. All right then.

While we might have thought HuffPo would have been absorbed into "the AOL Way" when it was bought last month, but as the Wall Street Journal's Jessica Vascellaro reported, it seems the reverse is happening: Arianna Huffington is doing away with parts of AOL's content farm-ish strategy and remaking it in her own image, Lipitor Price. That seems to be good thing, but there is a less happy side, too: Job cuts. By this week, Is Lipitor addictive, they had hit freelancers in just about every content area at AOL — business and finance (though some will apparently be hired into full-time jobs), TV, and movies. (In the latter case, the executive asked laid-off stringers to continue writing for free, then got fired herself.)

All these cuts weren't exactly unexpected, but that didn't make them popular, buy Lipitor from canada, of course. Laid-off freelancer Carter Maness described his frustration at the way AOL handled the move, and Forbes' Jeff Bercovici wondered if the laid-off writers might have a case for termination without notice under New York law. Lipitor Price, Others are chafing under Huffington's labor conditions, too: In the Los Angeles Times, Michael Walker compared the Newspaper Guild's boycott of HuffPo with the 1979 Comedy Store strike. Bercovici criticized the comparison, arguing that the work of HuffPo's unpaid bloggers is of relatively little value to the site. Lipitor photos, TechCrunch's Paul Carr (also part of the AOL empire) couldn't muster much sympathy. The value of writing for the Huffington Post, he said, is greater than the sacrifice of writing for free. Carr also asserted that most of the laid-off writers weren't producing much of value anyway. "A mass cull of non-talent is exactly what Arianna Huffington needed to do to assert her editorial authority over Aol’s content," he wrote. Meanwhile, the American Journalism Review took a look at some of the real talent that's left — the (paid) reporters who have left prestigious news outlets to write for HuffPo, Lipitor Price.

—

The aggregation-original reporting showdown: Ever since this passive-aggressive column by New York Times editor Bill Keller, Lipitor steet value, the Times and the Huffington Post have been engaging in an odd little tiff with the general theme of "aggregation vs. original reporting." Both sides kept up the fight this week, in the form of an April Fool's paywall announcement by Huffington and a nasty interview of Huffington in the New York Times Magazine. Reuters' Felix Salmon also documented the Times' refusal to credit (or link to) HuffPo when writing about a few government documents it leaked.

Several observers attempted to make some sense of this conflict, Australia, uk, us, usa, and the Times didn't come out well in any of those analyses. Lipitor Price, Salmon said the Times is lashing out because it's feeling threatened by HuffPo, and New York's Chris Rovsar argued that in order to sell it's paid-content plan, the Times is "turning Arianna Huffington into a straw man, using a caricature of her standards to better frame their own." CUNY j-prof Jeff Jarvis tried to lay out exactly what the Times thinks is wrong with HuffPo: It's not actually content, but instead conversation and aggregation, which is a) worthless, and b) cheating.

Aaron Bady made a deeper version of Rovsar's point, drawing on a paper presented last weekend by CUNY j-prof C.W. Anderson, who argued that while the lines between "aggregating" and "original reporting" are talked about as if they're clear, they are pretty blurry and unstable. Bady then concluded that both Keller and Huffington are trying to stake out their status as the center of Real Journalism by painting the other as being less than real, Lipitor cost. The Online Journalism Review's Robert Niles argued that all reporting is aggregation, though Anderson was skeptical.

—

Defending the Times' meter: As Bady noted, the Times has a huge incentive to defend its journalistic turf right now — a newly instituted plan to begin charging for its online content, Lipitor Price. Times execs addressed some of the conversation (and criticism) swirling around its pay system in a panel at Columbia University (audio here). Times Publisher Arthur Sulzberger Jr. disputed reports that the paper spent $40 million to develop the plan, and paidContent's Staci Kramer reported that the number is actually closer to $25 million — including about a third of the company's 2010 capital investment. Lipitor from canadian pharmacy, In the discussion, Sulzberger also ridiculed the idea that the Times' pay system is too complex, sarcastically comparing it to print subscription plans, He also likened getting around the pay plan online to stealing a paper from the newsstand, as he's described it in the past. (The Columbia Journalism Review also has a couple of notes about Sulzberger's comments about possible threats from HuffPo and the Wall Street Journal.)

Another news organization entered into the Times meter-beating space late last week: The Atlantic Wire, with a daily summary of what from the Times is most worth reading, real brand Lipitor online. The Lab's Megan Garber explained Lipitor Price, why she thinks it's more of a "respectful tribute" to the Times than the stereotypical parasitic aggregation.

—

SB Nation's gain is AOL's loss: The sports blog network SB Nation made the week's most intriguing personnel move when it snapped up the team behind the popular tech blog Engadget to make its own move into the world of gadget/tech blogging. PaidContent's Staci Kramer talked to SB Nation CEO Jim Bankoff about why the move into tech makes sense (advertisers are looking for "young, tech-savvy, affluent males" — the same demographic targeted by sports blogs).

Of course, My Lipitor experience, this story, too, ties into AOL, as Engadget is an AOL blog, and Bankoff is the guy who brought it into the AOL fold back in 2005. The New York Times' David Carr, who broke the story, online buying Lipitor hcl, used the defections as a cautionary tale for AOL, concluding that "AOL has found a way to acquire what it cannot build, but it still hasn’t found a way to hang on to what it has."

Outgoing Engadget editor-in-chief Joshua Topolsky hinted at his beef with AOL in his post announcing the move, saying SB Nation believes in new media's potential as an "antidote to big publishing houses and SEO spam." And while Arianna Huffington is helping AOL move away from the "AOL Way" that the Engadget folks disliked so much, GigaOM's Mathew Ingram noted that her strategy is new and internal suspicions about it are likely to be high. Meanwhile, Business Insider's Nicholas Carlson argued that readers don't care who's in charge of Engadget, Lipitor Price. Kjøpe Lipitor på nett, köpa Lipitor online, —

Reading roundup: Other stuff happened outside the AOL/Huffington Post/New York Times bubble — honest. Here's a quick overview:

— The University of Texas held its annual International Symposium on Online Journalism last weekend, and University of British Columbia j-prof Alfred Hermida blogged the heck out of it, producing 16 posts on the conference's panels and speakers. A few posts to check out in particular: Former NPR CEO Vivian Schiller's reasons for optimism about journalism, poor use of Twitter by mainstream media outlets, and lessons on audience engagement, taking Lipitor. I also summarized the conference's main themes.

— Some paid-content notes: British advertising magnate Sir Martin Sorrell argued Lipitor Price, for the media to charge for news online (alongside government subsidy), but GigaOM's Mathew Ingram thought his idea was terrible. Elsewhere, the San Francisco Chronicle is jumping on the paid-content train, and the AP's Jonathan Stray proposed an open-API paid syndication system between content creators and aggregators.

— For the sports-media crowd: Dallas Mavericks owner and former Yahoo mogul Mark Cuban tried to parse out what media sources should and shouldn't be allowed in locker rooms. Lipitor schedule, Dan Shanoff of Quickish broke down Cuban's points, and Craig Calcaterra of NBC Sports' Hardball talk issued a defense of paid bloggers and reporters in general.

— The local content network Examiner.com is often seen as one of the web's "content farms," but it took a couple of steps toward higher quality this week, producing a white paper that analyzed their quality issues and proposed pay incentives based on quality guidelines, and adding several respected media folks to its advisory board.

— If you're wondering how The Daily is doing, buying Lipitor online over the counter, it's tough to find solid information, since News Corp. is keeping it close to the vest. But the Lab's Josh Benton find a nifty way to guesstimate its engagement by measuring in-app tweets. Here's the resulting data, in two fascinating posts.

July 5th, 2010

Synthroid Price

[This review was originally posted at the Nieman Journalism Lab Synthroid Price, on June 11, 2010.]

The Times has the Pulse (briefly) pulled: Last week, I noted one of the more interesting iPad news apps: The Pulse Reader, designed by two Stanford grad students, is a stylish news aggregator. But on Monday, the app was pulled from the iTunes store based on a claim that it infringes on The New York Times' copyright after some Times folks saw the paper's own blog post about the reader. The app was reinstated the next day, but the debate over copyright, aggregation and mobile apps had already taken off.

The central point of the Times' argument was that the $3.99 app was an illegal attempt to make money off of the Times' (and the Boston Globe's) free, publicly available RSS feeds, rx free Synthroid. (The paper also objected to app's placement of the Times' content within a frame on the iPad.) The Citizen Media Law Project's Kimberley Isbell helpfully broke down the Times' claims and the Pulse Reader's possible fair-use defenses, noting the Times articles' free accessibility and the relatively small article portions displayed on the reader.

Reaction on the web weighed overwhelmingly against the Times: Wired contended that every piece of paid software used to access the Times' site would be outlawed by the paper's logic, while Techdirt's Mike Masnick argued that Pulse was selling its software, not the Times' feeds, Synthroid Price. GigaOm's Mathew Ingram wondered whether the Times was declaring war on news aggregators, and the Sydney Morning Herald reasoned that if the Times is offering its RSS for free, it can't complain when someone designs a reader to view it. Blogging and RSS vet Dave Winer had the harshest response in a post arguing that the Times is in the business of news production, Fast shipping Synthroid, not distribution: "Look, if the Times is depending on stopping those two kids for its future, then the Times has no future."

The reader's creators were just as baffled as anybody about why the app was reinstated, a Times' spokesman apparently tried to pass off the complaint as a mistake, though that response doesn't exactly square with the Times' Martin Nisenholtz's reiteration of the paper's case to paidContent's Staci Kramer. As for whether this claim would apply beyond the Pulse Reader, Nisenholtz said it would be handled "on a case by case basis."

We had plenty of other iPad news this week, too — Jobs made a number of mostly iPhone-related announcements at a conference on Monday, Synthroid recreational, and the Lab's Josh Benton explained what they mean for mobile news. A few highlights: Apple's not too concerned about app-banning controversies, but it is moving decisively on ebooks and its iAd mobile advertising platform. The AP reported that publishers are seeing encouraging early signs Synthroid Price, about wringing advertising dollars out of the iPad, but Ken Doctor went on a wonderful little rant against publishers that are slow to take advantage of the iPad's capabilities. Meanwhile, the Wall Street Journal's Robert Thomson slammed news orgs' repurposed "crapps" and talked, with the Journal's Les Hinton, Buy cheap Synthroid, about his paper's own iPad strategy. And the iPad faced its first major security issue, as the email addresses of its 114,000 owners were exposed by hackers.

—

The purpose of the link: A Nicholas Carr post last week ignited a spirited discussion about the relative values of the link, and that conversation continued this week with twin Wall Street Journal columns by Carr and web scholar Clay Shirky debating whether the Internet makes us smarter. Carr said no, using a similar argument to the one he laid out in his earlier post (it's also the central point of his new book): The Internet encourages multitasking and bite-size information, making us all "scattered and superficial thinkers."Shirky said yes, Synthroid without prescription, arguing that the Internet enables never-before-experienced publishing and connective capabilities that allow us to put our cognitive surplus to work for a better society. (That's also the central point of his new book.) Quite a few people, led by GigaOm's Mathew Ingram, posited that both writers were right - Carr in the short term, Shirky in the long term.

Here at the Lab, Jason Fry weighed in on the delinkification debate, giving a useful classification of the link's primary purposes — credibility, readability and connectivity, Synthroid Price. Credibility has become a vital function in today's web, Synthroid for sale, Fry said, though he conceded Carr's point that the link adds to the cognitive load when it comes to readability. Based on Carr's original post, the web design firm Arc90 added an option to its browser extension to convert hyperlinks to footnotes.

The Lab also ran a fantastic three-part series on links by Jonathan Stray exploring four journalistic purposes of the hyperlink (it's essential, he says), examining the way news organizations talk about links (they're a bit muddled) and studying how much those news organizations actually link (not a whole lot, especially the wire services), Synthroid trusted pharmacy reviews. It's a tremendously helpful resource for anyone interested in looking at how linking and journalism intersect.

—

Debate over Newsweek's bidders: We found out about three bidders for Newsweek Synthroid Price, last Thursday, so last Friday was the time for profiles and commentary, much of it centered on the conservative news site and magazine Newsmax. Newsmax's CEO, Christopher Ruddy, told the Washington Post that it has a number of non-conservative media projects, so Newsweek wouldn't have to adopt a conservative viewpoint to be part of Newsmax's plans. "Newsmax's success is in its business model, Synthroid dose, not just its editorial approach," Ruddy said. Newsweek employees were worried about the prospect of a Newsmax-owned Newsweek, but the New York Times' Ross Douthat, himself a conservative, said Newsmax's influence could be just the nudge Newsweek needs to hit its sweet spot in America's heartland. Chicago magazine profiled another bidder, venture capitalist Thane Ritchie, Synthroid pics, while the Washington Post reported that audio equipment exec Sidney Harman is considering a bid, too.

Washington Post media critic Howard Kurtz devoted a column to the publicly acknowledged bidders, exploring the question of why no major players have emerged as bidders and concluding that the lack of interest "amounts to a no-confidence vote not just on the category of newsweeklies, which have long been squeezed between daily papers and in-depth monthlies, but on print journalism itself." Newsweek, via its Tumblr, ripped apart the work of its Washington Post Co, Synthroid Price. colleague, taking to task for a lack of evidence and disputing his claim that the re-envisioned Newsweek is a flop. (That Tumblr is written by Newsweek social-media guru David Coatney, who got a New York Daily Intel Q&A a couple of days later.) Meanwhile, Synthroid natural, New York Times columnist David Carr proposed eight ways to revive Newsweek.

—

A sports blog network goes local: ESPN has been making a well-documented and initially successful local sports media play over the past year, but this week, a very different sports media company is making a push into what used to be local newspapers' territory. SB Nation, a network of more than 250 fan-run sports blogs founded in 2003 by Tyler Bleszinski and Daily Kos' Markos Moulitsas Zuniga, began rolling out 20 city-specific sports media hubs. Synthroid Price, Until now, the company has focused on team-specific (or sport-specific, in the case of some less prominent sports) blogs, but the new sites will aggregate real-time sports news mixed with fan-generated conversation and commentary.

In a New York Times feature, generic Synthroid, SB Nation's Jim Bankoff said that while his company is trying to provide a ground-up alternative to traditional sports coverage, he'd be happy to collaborate with local newspapers. Former ESPN.com columnist Dan Shanoff echoed that perspective, saying that SB Nation's brand of sharp fan analysis is ripe for media partnerships because "it is something that local newspapers and local cable-sports networks can't or won't do well." Shanoff proposed that SB Nation become a piece of a larger media company's local media strategy, suggesting Comcast as an ideal fit.

Here at the Lab, Is Synthroid addictive, Bankoff gave Laura McGann a handful of lessons media organizations could learn from the SB Nation model, including tightly focused subject matter and maximizing repeat visitors. SB Nation's team-specific focus seems to be a major component in its success, and could have some ready implications for news organizations, as Bankoff noted: “We’re not fans of sports — we’re fans of teams. We’re not fans of television, Synthroid Price. We’re fans of shows.”

—

Reading roundup: This week, I've got two news items, a few interesting pieces of commentary and one set of tips, purchase Synthroid online no prescription.

— Advertising Age reported that AOL is planning to hire hundreds of journalists for a major expansion into news production. At the local media blog Lost Remote, Cory Bergman, who owns a local news network himself, noted that AOL's hyperlocal outfit Patch is making 300 of those hires and wondered what it will mean for local news.

— Los Angeles Times media writer James Rainey wrote a piece on the Las Vegas Review-Journal, a newspaper that has poured legal resources into stopping people who use its content without permission. The Times' Mark Milian also provided a quick guide Synthroid Price, to what's OK and what's not when reposting.

— Publish2's Scott Karp wrote an intriguing essay on the concept of a Content Graph, in which media organizations collaborate through distribution to enhance their brand's value.

— News business guru Alan Mutter sensed a theme among news startups — too much focus on news, not enough on business — and wrote a stiff wakeup call.

— Two journalism/tech folks, japan, craiglist, ebay, overseas, paypal, Jeff Sonderman and Michelle Minkoff, wrote a bit about what journalism school is — and isn't — good for. Both are worthwhile reads.

— Finally, British journalism David Higgerson has 10 ideas for building good hyperlocal websites. Most of his (very practical) ideas are useful not just for hyperlocal journalism, but for online news in general.

Mark Coddington

Associate Professor, Washington and Lee University

Buy Tramadol No Prescription

Lipitor Price

Synthroid Price